Publications by authors named "J Alejandro Perez-Fidalgo"

Claim this Profile
A
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial.
Philipp Harter, Frederik Marmé, Andrés Redondo, Alexander Reuss, Kristina Lindemann

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy and PARP inhibitors as first-line treatment in endometrial cancer: A systematic review and network meta-analysis.
Guillermo Villacampa, Gemma Eminowicz, Victor Navarro, Lorenzo Carità, David García-Illescas

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial.
Antonio González-Martín, María Jesús Rubio, Florian Heitz, René Depont Christensen, Nicoletta Colombo

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gestational breast cancer: distinctive molecular and clinico-epidemiological features.
J R de la Haba-Rodríguez, P Mínguez, F Rojo, M Martín, E Alba

J Mammary Gland Biol Neoplasia· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Survival Outcomes of Gastrointestinal Stromal Tumors.
Christian S Alvarez, M Blanca Piazuelo, Tania Fleitas-Kanonnikoff, Jennifer Ruhl, J Alejandro Pérez-Fidalgo

JAMA Netw Open· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis